Eli Lilly Dives As Zepbound Takes A Back Seat To Novo Nordisk's Wegovy At CVS
In This Article:
Eli Lilly topped expectations Thursday, but shares tumbled after CVS selected Novo Nordisk's Wegovy as its preferred weight-loss drug.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Eli Lilly topped expectations Thursday, but shares tumbled after CVS selected Novo Nordisk's Wegovy as its preferred weight-loss drug.